These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Chen F; Kishida T; Duh FM; Renbaum P; Orcutt ML; Schmidt L; Zbar B Cancer Res; 1995 Nov; 55(21):4804-7. PubMed ID: 7585510 [TBL] [Abstract][Full Text] [Related]
9. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy. Lam JS; Belldegrun AS; Figlin RA Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022 [TBL] [Abstract][Full Text] [Related]
10. Molecular markers for renal cell carcinoma: impact on diagnosis and treatment. Zhou M; Rubin MA Semin Urol Oncol; 2001 May; 19(2):80-7. PubMed ID: 11354537 [TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma: basic biology and clinical behavior. Franklin JR; Figlin R; Belldegrun A Semin Urol Oncol; 1996 Nov; 14(4):208-15. PubMed ID: 8946619 [TBL] [Abstract][Full Text] [Related]
12. [Molecular biology of renal cancer: bases for genetic directed therapy in advanced disease]. Maroto Rey JP; Cillán Narvaez E Arch Esp Urol; 2013 Jun; 66(5):517-23. PubMed ID: 23793769 [TBL] [Abstract][Full Text] [Related]
13. [Traditional and future criteria for progression in renal cell carcinoma. Molecular biology and clinical aspects]. Pomer S; Staehler G Urologe A; 1996 May; 35(3):254-62. PubMed ID: 8711834 [TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma: current status and emerging therapies. Nelson EC; Evans CP; Lara PN Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029 [TBL] [Abstract][Full Text] [Related]
15. Management of metastatic renal cell carcinoma: current trends. Mohammed A; Shergill I; Little B Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350 [TBL] [Abstract][Full Text] [Related]
16. An overview of renal cell cancer: pathology and genetics. Moch H Semin Cancer Biol; 2013 Feb; 23(1):3-9. PubMed ID: 22722066 [TBL] [Abstract][Full Text] [Related]
18. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management. Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications. Poston CD; Jaffe GS; Lubensky IA; Solomon D; Zbar B; Linehan WM; Walther MM J Urol; 1995 Jan; 153(1):22-6. PubMed ID: 7966777 [TBL] [Abstract][Full Text] [Related]